Evidence map›Paper›PMID 39878467›Full record

ArticlemSphere2025

Virus-like particle-based vaccines targeting the

Alexandra Francian, Yevel Flores-Garcia, John R Powell, Nikolai Petrovsky, Fidel Zavala, Bryce Chackerian

Abstract read
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Alexandra FrancianDepartment of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Yevel Flores-GarciaW. Harry Feinstone Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
John R PowellDepartment of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Nikolai PetrovskyVaxine Pty Ltd., Adelaide, Australia.
Fidel ZavalaW. Harry Feinstone Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-1414-6196
Bryce ChackerianDepartment of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.ORCID 0000-0002-5712-4739

Funding

Unfolded Protein Response and Autophagy in T Helper Cell Effector FunctionP20GM121176 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI June Bryan de la Pena · 2017 to 2026
$24.9M
FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
Virus-like Particle based malaria vaccines targeting vulnerable epitopes in the circumsporozoite proteinR01AI169739 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Bryce C Chackerian · 2023 to 2026
$2.5M
NIAID NIH HHS R01 AI169739NIGMS NIH HHS K12 GM088021NIGMS NIH HHS P20 GM121176
6 · The paper itself

Abstract

Malaria is a highly lethal infectious disease caused by

Indexed as

AnophelesInsect ProteinsMalaria VaccinesSalivary Proteins and PeptidesVaccines, Virus-Like ParticleAnimalsAntibodies, ProtozoanFemaleMalariaMiceMice, Inbred BALB CPlasmodium falciparumProtozoan ProteinsAntibodies, ProtozoanInsect ProteinsMalaria VaccinesProtozoan ProteinsSalivary Proteins and PeptidesVaccines, Virus-Like Particlemalariamosquitovaccinesvirus-like particles

Identifiers

PMID39878467
PMCPMC11852919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.